Your session is about to expire
← Back to Search
Soy Isoflavones for Breast Cancer
Study Summary
This trial is studying whether soy isoflavones can prevent or treat early stage breast cancer in women who are at high risk for the disease.
- BRCA1 Mutation
- BRCA2 Mutation
- Ductal Carcinoma
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have allergies to certain foods like soy or nuts.You have a family history that suggests a higher risk of inherited breast cancer.You don't eat soy products regularly (less than once a week).You are not willing to avoid eating soy foods or taking soy supplements during the study.
- Group 1: Arm I
- Group 2: Arm II
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must be met in order to qualify for participation in this research project?
"Eligibility for this trial requires that patients suffer from carcinoma and are between 30 to 75 years old. This research aims to recruit 110 participants in total."
Does this research program have any age restrictions?
"This study's eligibility guidelines call for patients aged between 30 and 75 years, while 133 trials are available to minors and 4502 studies target seniors."
Is this research initiative currently seeking participants?
"Indications on clinicaltrials.gov reveal that this specific trial is not in the process of recruiting patients, having first been posted on July 1st 2010 and most recently updated November 12th 2022. However, there are 4610 other trials actively looking for volunteers at present."
Share this study with friends
Copy Link
Messenger